CRISPR Therapeutics AG (CRSP) - Market Value

Public company logo of crisprtx.com (CRSP)

The market dynamics of CRISPR Therapeutics AG (CRSP) securities demonstrate a capitalization of 3.92 for this genetic therapy leader. High R&D costs and patent protection block new entrants, amplifying the influence of lobbyists under strict FDA oversight. Business success depends on test results rather than macroeconomics or Fed policy. Streamlined biocomponent supply chains ensure the stability of all research.

CRSP crisprtx.com: Market Valuation in the range 07/04/2022 - 11/17/2026

CRISPR Therapeutics AG - analytical breakdowns and key metrics (CRSP)

- market price and analyst price targets:
Fundamental company analysis:CRISPR CRSP
Original product of CRISPR

The success of CRISPR Therapeutics AG (CRSP) is driven by the effective implementation of its first gene therapy and the quality of its logistics, rendering the company's market capitalization an indicator of market confidence in its commercialization. This metric is calculated as the product of the current share price and the total number of outstanding shares, allowing investors to perform a real-time assessment of the issuer's total equity and the resilience of its position given a significant liquidity reserve.

Competitors of CRISPR Therapeutics AG (CRSP)

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Capitalization WGS|RARE (Ultragenyx Pharmaceutical) - Market Capitalization|Market Capitalization BEAM (Beam Tx)|Market Value Sarepta (SRPT)|Twist Bioscience - Market Capitalization|Market Capitalization TXG (10x Genomics, Inc.)|Market Capitalization Intellia Therapeutics, Inc. NTLA|STOK - Market Value|BLFS: Market Value|WVE (Wave Life Sciences) - Market Valuation|Maze Therapeutics (MAZE) - Market Capitalization|Market Value Sionna Corp|Prime Medicine Inc (PRME) - Market Capitalization|Market Value Taysha Corp (TSHA)|uniQure N.V. (QURE) - Market Capitalization|Market Capitalization MGTX (MeiraGTx Corp)|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.